ScholarIQanswers from OpenAlex
GW Pharmaceuticals
FunderResearch funding and supported work
GW Pharmaceuticals is a funder indexed in ScholarIQ from OpenAlex.
What is known about GW Pharmaceuticals?
ScholarIQrecord summary
British biopharmaceutical company
How many works does GW Pharmaceuticals have?
ScholarIQindexed works
GW Pharmaceuticals has 904 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for GW Pharmaceuticals?
ScholarIQopenalex
The OpenAlex for GW Pharmaceuticals is on the source record.
What is the ROR of GW Pharmaceuticals?
ScholarIQror
The ROR for GW Pharmaceuticals is on the source record.
What are the most-cited papers on GW Pharmaceuticals?
ScholarIQmost cited works
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
The ADVANCE Collaborative Group
Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder
Michael Siani-Rose, Stephany Cox, Bonni Goldstein, Donald I. Abrams, Myiesha Taylor, Itzhak Kurek
Cannabidiol blood metabolite levels after cannabidiol treatment are associated with broadband EEG changes and improvements in visuomotor and non-verbal cognitive abilities in boys with autism requiring higher levels of support
Christian Cazares, Austin Hutton, Gisselle Paez, Doris Trauner, Bradley Voytek